Search Results - "LADERACH, Diego J"

A Unique Galectin Signature in Human Prostate Cancer Progression Suggests Galectin-1 as a Key Target for Treatment of Advanced Disease by LADERACH, Diego J, GENTILINI, Lucas D, SHIPP, Margaret A, VAZQUEZ, Elba, CHAUCHEREAU, Anne, KUTOK, Jeffery L, RODIG, Scott J, ELOLA, MariaT, COMPAGNO, Daniel, RABINOVICH, Gabriel A, GIRIBALDI, Laura, CARDENAS DELGADO, Victor, NUGNES, Lorena, CROCI, Diego O, AL NAKOUZI, Nader, SACCA, Paula, CASAS, Gabriel, MAZZA, Osvaldo

“…Galectins, a family of glycan-binding proteins, influence tumor progression by modulating interactions between tumor, endothelial, stromal, and immune cells…”
Get full text

Galectin-1 Triggers Epithelial-Mesenchymal Transition in Human Hepatocellular Carcinoma Cells by Bacigalupo, María L., Manzi, Malena, Espelt, María V., Gentilini, Lucas D., Compagno, Daniel, Laderach, Diego J., Wolfenstein-Todel, Carlota, Rabinovich, Gabriel A., Troncoso, María F.

“…Galectin‐1 (Gal1), a β‐galactoside‐binding protein abundantly expressed in tumor microenvironments, is associated with the development of metastasis in…”
Get full text

Dissecting the signal transduction pathways triggered by galectin–glycan interactions in physiological and pathological settings by Laderach, Diego J., Compagno, Daniel, Toscano, Marta A., Croci, Diego O., Dergan‐Dylon, Sebastián, Salatino, Mariana, Rabinovich, Gabriel A.

“…Galectins are a family of evolutionarily conserved animal lectins with pleiotropic functions and widespread distribution. Fifteen members have been identified…”
Get full text

Delineating the "galectin signature" of the tumor microenvironment by Compagno, Daniel, Laderach, Diego J., Gentilini, Lucas, Jaworski, Felipe M., Rabinovich, Gabriel A.

“…Galectins, a family of glycan-binding proteins, can control tumor progression by promoting transformation, angiogenesis and immune escape. We identified a…”
Get full text

Galectins as New Prognostic Markers and Potential Therapeutic Targets for Advanced Prostate Cancers by Laderach, Diego J., Gentilini, Lucas, Jaworski, Felipe M., Compagno, Daniel

“…A better understanding of multimolecular interactions involved in tumor dissemination is required to identify new effective therapies for advanced prostate…”
Get full text

In Vivo Hemin Conditioning Targets the Vascular and Immunologic Compartments and Restrains Prostate Tumor Development by Jaworski, Felipe M, Gentilini, Lucas D, Gueron, Geraldine, Meiss, Roberto P, Ortiz, Emiliano G, Berguer, Paula M, Ahmed, Asif, Navone, Nora, Rabinovich, Gabriel A, Compagno, Daniel, Laderach, Diego J, Vazquez, Elba S

“…Conditioning strategies constitute a relatively unexplored and exciting opportunity to shape tumor fate by targeting the tumor microenvironment. In this study,…”
Get full text

Glycans and galectins in prostate cancer biology, angiogenesis and metastasis by Compagno, Daniel, Gentilini, Lucas D, Jaworski, Felipe M, Pérez, Ignacio González, Contrufo, Geraldine, Laderach, Diego J

“…Prostate cancer is the second most common cause of cancer and the sixth leading cause of cancer death among men worldwide. While localized prostate cancer can…”
Get full text

Study of galectins in tumor immunity: strategies and methods by Cerliani, Juan P, Dalotto-Moreno, Tomas, Compagno, Daniel, Dergan-Dylon, L Sebastián, Laderach, Diego J, Gentilini, Lucas, Croci, Diego O, Méndez-Huergo, Santiago P, Toscano, Marta A, Salatino, Mariana, Rabinovich, Gabriel A

“…During the past decade, a better understanding of the cellular and molecular mechanisms underlying tumor immunity has provided the appropriate framework for…”
Get more information

Regulation of galectins by hypoxia and their relevance in angiogenesis: strategies and methods by Salatino, Mariana, Croci, Diego O, Laderach, Diego J, Compagno, Daniel, Gentilini, Lucas, Dalotto-Moreno, Tomas, Dergan-Dylon, L Sebastián, Méndez-Huergo, Santiago P, Toscano, Marta A, Cerliani, Juan P, Rabinovich, Gabriel A

“…Formation of an aberrant and heterogeneous vascular network is a key pathological event in the multistep process of tumor growth and metastasis. Pro-angiogenic…”
Get more information

Abstract 3960: Low doses of Docetaxel in combination with anti-prostate cancer immunotherapy lead to complete tumor-free outcome through Galectin-3 silencing by Compagno, Daniel, Tiraboschi, Carolina, Gentilini, Lucas, Corapi, Enrique, Jaworski, Felipe M., Chauchereau, Anne, Laderach, Diego J.

“…Based on animal model results and the analysis of clinical data from metastatic and castration resistant prostate cancer (mCRPC) patients, we were able to…”
Get full text

Abstract 453: Engineering the tumor microenvironment: Hemin conditioning in vivo impairs tumor growth and reprograms the immune-modulatory response in prostate cancer by Jaworski, Felipe M., Gueron, Geraldine G., Gentilini, Lucas D., Leonardi, Daiana B., González Pérez, Ignacio, Contrufo, Geraldine, Rabinovich, Gabriel A., Compagno, Daniel G., Laderach, Diego J., Vazquez, Elba S.

“…Prostate cancer (PCa) is the second leading cause of cancer death in men in the United States, and inflammation is recognized as a risk factor. In this regard…”
Get full text